EUVIMEDEUVIMED entdecken
Crossref

Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2

Nina Boe, Victor F Mautner, Reinhard E Friedrich, Said C Farschtschi, Lasse Dührsen, Hanno S Meyer, Johannes A Koeppen

Anticancer Research · 2025-05 · 45 (5) · 2137-2146

DOI: 10.21873/anticanres.17588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 28.04.2025. Verfasst von Nina Boe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany nina.boe@gmx.net. Hauptthemen laut MEDLINE: Neurofibromatosis 2, Neuroma, Acoustic, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: NF2-related schwannomatosis, formerly known as Neurofibromatosis type 2 (NF2) is characterized by bilateral vestibular schwannomas (VS). Managing NF2 requires balancing watchful waiting with surgical intervention, each carrying inherent risks. While these risks are acknowledged, they have not yet been subjected to systematic investigation. Accurate prognosis of tumor growth is crucial for clinical decision-making. This study investigated radiomics features from longitudinal magnetic resonance imaging (MRI) data to predict VS growth. PATIENTS AND METHODS: Radiomics features were extracted from cranial MRIs of 32 NF2 patients, each with at least two or more imaging time points. The association between these features and tumor growth was analyzed through correlation, visual inspection, and the Boruta algorithm. RESULTS: Correlations between growth rates and radiomics features were weak (ρ≤0.23, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 2Neuroma, AcousticMagnetic Resonance ImagingHumansFemaleMaleMiddle AgedAdultPrognosisAgedYoung AdultRadiomics

Stichwörter der Autor:innen

Boruta analysisNF2growth predictionradiomicsvestibular schwannomas

Autor:innen und Institutionen

  • Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany nina.boe@gmx.net.
  • Department of Neurology, University Hospital Hamburg Eppendorf, Hamburg, Germany.
  • Department of Oral and Maxillofacial Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany.
  • Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany.
  • Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany koeppen@ieee.org.

Zitieren

APA

Boe, N., Mautner, V. F., Friedrich, R. E., Farschtschi, S. C., Dührsen, L., Meyer, H. S., & Koeppen, J. A. (2025). Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2. Anticancer Research, 45(5), 2137-2146. https://doi.org/10.21873/anticanres.17588

Vancouver

Boe N, Mautner VF, Friedrich RE, Farschtschi SC, Dührsen L, Meyer HS, et al. Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2. Anticancer Research. 2025;45(5):2137-2146. doi:10.21873/anticanres.17588

BibTeX
@article{Boe2025,
  author = {Boe, Nina and Mautner, Victor F and Friedrich, Reinhard E and Farschtschi, Said C and Dührsen, Lasse and Meyer, Hanno S and Koeppen, Johannes A},
  title = {Radiomics for Growth Prediction of Vestibular Schwannomas in Neurofibromatosis Type 2},
  journal = {Anticancer Research},
  year = {2025},
  volume = {45},
  number = {5},
  pages = {2137--2146},
  doi = {10.21873/anticanres.17588}
}
Kostenlos starten →